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Abstract
Background: Brucellosis is a worldwide anthropozoonotic disease caused by an in vivo intracellular pathogen
belonging to genus Brucella. The characterization of brucelae transcriptome’s during host-pathogen interaction has
been limited due to the difficulty of obtaining an adequate quantity of good quality eukaryotic RNA-free pathogen
RNA for downstream applications.
Findings: Here, we describe a combined protocol to prepare RNA from intracellular B. melitensis in a quantity and
quality suitable for pathogen gene expression analysis. Initially, B. melitensis total RNA was enriched from a host:
pathogen mixed RNA sample by reducing the eukaryotic RNA. Then, to increase the Brucella RNA concentration
and simultaneously minimize the contaminated host RNA in the mixed sample, a specific primer set designed to
anneal to all B. melitensis ORF allows the selective linear amplification of sense-strand prokaryotic transcripts in a
previously enriched RNA sample.
Conclusion: The novelty of the method we present here allows analysis of the gene expression profile of B.
melitensis when limited amounts of pathogen RNA are present, and is potentially applicable to both in vivo and in
vitro models of infection, even at early infection time points.
Background
Brucellosis is a worldwide anthropozoonotic disease
caused by small intracellular Gram negative coccobacilli
belonging to genus Brucella. In spite of the massively
underreported cases, brucellosis is considered the
world’s most widespread zoonotic infection [1]. Basi-
cally, human brucellosis is an occupational-related dis-
ease associated with accidental contact with infected
animals or clinical specimens, inhalation of infected
aerosolized particles, or a food-borne disease associated
with the consumption of contaminated animal products
[2]. Clinically, human brucellosis is an incapacitating
disease which presents a spectrum of severity and symp-
toms varying dependent on the species of Brucella. B.
melitensis causes the most severe and acute symptoms
in humans such as intermittent fever, chills, sweats,
weakness, myalgia, osteoarthricular complications, endo-
carditis, depression and anorexia, frequently resulting in
chronic debilitating illness [3].
To date, little is known about Brucella gene expres-
sion during host:pathogen interaction. The published
studies have relied on the use of gfp reporter gene sys-
tem [4] or transposon mutagenesis [5] rather than direct
analysis of Brucella transcripts. The characterization of
the transcriptome of intracellular pathogens during
host-pathogen interaction has been limited due to the
difficulty of obtaining an adequate quantity of good
quality eukaryotic RNA-free pathogen RNA for down-
stream applications. Basically, until now few experimen-
tal approaches were designed to minimize the presence
of eukaryotic RNA and increase the relative amount of
pathogen RNA collected from infected cells. One
approach is to lyse infected host cells with an ice-cold
mixture of acid phenol, ethanol and detergent, followed
by collection by centrifugation and RNA extraction
using a standard RNA purification procedure [6]. Gene
expression profiles of intramacrophage Salmonella
typhimurium, Listeria monocytogenes and Shigella flex-
neri were studied using this methodology [6-8]. Another
successful approach developed entails lysing host cells
with cold water, followed by enzymatic digestion of host
genetic material with RNase and DNase while bacteria
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approach consists of isolation of total RNA from
infected cells, followed by removal of host mRNA using
oligo(dT) columns or magnetic beads, or by greatly
reducing host RNA through selective reverse transcrip-
tion of bacterial mRNA. The intracellular transcriptional
profile of Chlamydia trachomatis during HeLa cells
infection, Burkholderia pseudomallei during acute
melioidosis in the hamster model of infection and Myco-
bacterium tuberculosis in infected mice were analyzed
by this procedure [10-12]. However, further studies are
limited by all these methodologies if small amounts of
pathogen mRNA is recovered, such as during early
infection time points. To have a sufficient template for
downstream applications, one possibility might be to
increase the concentration of the inoculum or the sam-
ples, i.e. more animals or tissues inoculated, which it is
not always possible. Another alternative would be to
amplify the pathogen mRNA isolated from a mixed
sample. Few methods to amplify signals from bacteria
transcripts have been reported. One method, Differential
Expression using Customized Amplification Libraries
(DECAL) [13], has not been demonstrated to work with
in vivo material. The method described by Motley et al.
(2004) produced antisense RNA which could not be
used to hybridize on the oligo-arrays [14], and like the
Linear Amplification of Prokaryotic Transcripts (LAPT)
[15], does not discriminate RNA populations during
amplification.
We have developed a combined protocol to prepare
RNA from intracellular B. melitensis in a quantity and
quality suitable for pathogen gene expression analysis.
First, B. melitensis RNA was enriched from a host:
pathogen mixed RNA sample, and then, the prokaryotic
transcripts were selectively amplified. The method we
present here allows analysis of the gene expression pro-
file of intracellular B. melitensis, even at early infection
time points when few numbers of pathogens are present.
Materials and methods
Bacterial strains, media and culture conditions
Smooth virulent Brucella melitensis 16 M Biotype 1
(ATCC 23456) (American Type Culture Collection,
Manassas, VA), re-isolated from an aborted goat fetus
was maintained as frozen glycerol stocks. Saturated cul-
tures were sub-cultured into tryptic soy broth (TSB)
(BD, Franklin Lakes, NJ) and incubated for 18 h with
shaking (200 rpm) at 37°C with 5% CO2 until the log
growth phase (OD600 = 0.9) was reached.
Isolation of total RNA and genomic DNA from
B. melitensis 16 M culture
B. melitensis total RNA and genomic DNA was isolated
as previously described [16]. Briefly for RNA isolation,
ice-cold ethanol/phenol solution was added to the
B. melitensis culture at late-log growth phase and the
bacteria recovered by centrifugation. The media was
then removed, and the pellet suspended in TE buffer-
lysozyme solution containing 10% SDS (Ambion). After
2 min of incubation, acid water-saturated phenol
(Ambion) was added to the lysate and mixed, and the
sample incubated for 6 min at 64°C. Tubes were kept
on ice for at least 2 min and then centrifuged at maxi-
mum speed. The upper layer, containing the RNA, was
transferred to a new tube, mixed with an equal volume
of chloroform (Sigma) and then separated by centrifuga-
tion. The aqueous phase was mixed with 100% cold
ethanol and stored at -20°C. After at least one hour of
incubation, RNA was pelleted by centrifugation, washed
in 80% ethanol and suspended in DEPC-treated water
(Ambion) with 2% (w/v) DTT and 1% (w/v) RNase inhi-
bitor (Promega). Contaminant genomic DNA was
removed by RNase-free DNase I treatment (Ambion)
according to the manufacturer’s instructions, and sam-
ples were stored at -80°C until used. RNA concentration
was quantified by NanoDrop® ND-1000 (NanoDrop),
and the RNA quality was assessed using the Agilent
2100 Bioanalyzer (Agilent).
For isolation of B. melitensis gDNA, a pellet from a
saturated culture of B. melitensis 16 M grown in tryptic
soy broth (TSB) (BD) was washed with 25 ml of J-buffer
[ 0 . 1MT r i sp H8 . 0 ;0 . 1ME D T A ;0 . 1 5MN a C l ]a n d
then lysed in 1 ml of J-buffer containing freshly made
10% lysozyme solution [10 mg/ml in 0.25 M Tris, pH
8.0] at 37°C for 10 min. Later, 0.1 ml of RNAse solution
(1 mg/ml) was added and incubated at 37°C for another
10 min. Finally, the solution was heated to 70°C for 3
min. DNA was released from the cells by adding 0.08
ml of 30% sodium salt of N-lauroyl sarcosine (Sigma)
and incubated at 37°C for 1 h, followed by digestion of
proteins by 4 mg of proteinase K. The resulting solution
was dialyzed against TE [10 mM Tris, pH 8.0 and
1 mM EDTA] overnight at 37°C. Next day, the prepara-
tion was transfered back to a plastic tube and DNA was
subsequently twice extracted with ten minute of gentle
inversion in neutral, water-saturated phenol, followed by
two-time ether extract. Finally, DNA was again dialyzed
for 8 h against TE. DNA concentration was quantified
by NanoDrop® ND-1000 (NanoDrop) and stored at 4°C
until used.
Isolation of total RNA from HeLa and MDBK cell lines
Total RNA from HeLa S3 and Madin-Darby bovine kid-
ney (MDBK) (ATCC) cell cultures was extracted by
TRI-Reagent® (Ambion, Austin, TX) according to manu-
facturer’s instructions. The resultant RNA pellet was
re-suspended in DEPC-treated water (Ambion) with 2%
DTT and 1% RNase inhibitor (Promega, Madison, WI).
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DNase I treatment (Ambion) according to the manufac-
turer’s instructions, and samples were stored at -80°C
until used. RNA concentration was quantified by Nano-
Drop® ND-1000 (NanoDrop, Wilmington, DE), and the
RNA quality was determined using the Agilent 2100
Bioanalyzer (Agilent, Palo Alto, CA).
Design of B. melitensis genome-directed primers
(BmGDPs)
GDPs were designed using GDP-Finder, a computer-
based algorithm that predicts the minimal number of
primers to specifically anneal to all ORFs in a given gen-
ome [17]. Searching for the first 500 bp of each ORF
complementary sequence, the algorithm predicted that
89 different reverse primers of 8-mer oligonucleotides
were required to anneal to the 3,198 B. melitensis ORFs
(Additional file 1). Primers were commercially synthe-
sized (Sigma Genosys, The Woodland, TX) and used for
reverse transcription during the first step of RNA ampli-
fication and for labeling the cDNA.
Enrichment and sense-strand amplification of B. melitensis
mRNA from mixed host-pathogen total RNA sample
B. melitensis total RNA was initially enriched from two
spiked samples of 25 μg of total RNA extracted from
HeLa or MDBK cells culture. The enrichment procedure
was performed using the MICROB Enrich® kit (Ambion)
according to the manufacturer’s instructions. After
enrichment, the remaining RNA was precipitated in
100% ethanol at -20°C for at least 1 h, centrifuged for
30 min at 10,000 × g at 4°C, and washed twice in ice-
cold 70% ethanol. After 5 min centrifugation at 10,000
× g at 4°C, the RNA was re-suspended in 25 μlo f
DEPC-treated water (Ambion) and immediately ampli-
fied in a 3 step-protocol, previously described in detail
[15]. Briefly, the total amount of RNA after the enrich-
ment procedure was reverse transcribed to cDNA in a
50 μl reaction using 42 μMo fBmGDPs, 5 μlo f5 0 ×
dNTPs (10 mM each) (Invitrogen, Carlsbad, CA), 2.5 μl
of PowerScript (Clontech, Palo Alto, CA), 2.5 μlo f
RNAsin (Promega), and 42 μM of T7 promoter-tem-
plate switching primer (T7-TS) (5’-CGAAATTAATAC-
GACTCACTATAGGGAGAGTACGCGGG-3’)( S i g m a
Genosys). The BmGDPs and the RNA were mixed and
heated at 70°C for 10 min before being placed on ice for
>3 min and addition of the T7-TS and reverse transcrip-
tion reagents. The first-strand and template switching
reaction were performed at 42°C for 90 min in a ther-
mocycler with a non-heated lid (DNA Engine, MJ
Research, Inc., Waltham, MA). In the next step, the sec-
ond-strand cDNA was synthesized by adding 1× final
concentration of 10× Advantage 2 Polymerase buffer
(Clontech), 1× final concentration of 50× dNTPs mix
(10 mM each) (Invitrogen), 2U of Rnase H (Roche,
Indianapolis, IN) and 1× final concentration of 50×
Advantage 2 Polymerase mix (Clontech) to the final
reaction volume of 150 μl. The components were mixed
and the reaction incubated in a heated-lid thermocycler
(DNA Engine, MJ Research, Inc.) with the following
cycle: 37°C for 5 min, 94°C for 2 min, 65°C for 1 min
and 75°C for 60 min. Double-stranded cDNA was puri-
fied using PCR purification kit (Qiagen, Valencia, CA),
eluted in 100 μl of nuclease-free water and concentrated
to 15 μl in a speed-vac with no heat. In the last step,
the in vitro transcription, using the double-stranded
cDNA as the template and T7 Megascript kit (Ambion)
in 40 μl reactions with an additional 400U of T7 poly-
merase (Ambion) and 20U of Rnase inhibitor SUPER-
ase-In (Ambion), was performed at 37°C for 16 h. RNA
was cleaned and recovered using RNeasy kit (Qiagen)
and eluted in 100 μl of nuclease-free water with 40U of
SUPERase-In.
Construction of B. melitensis cDNA microarrays
Microarrays containing all B. melitensis 16 M ORFs
were designed at the Pathogen Expression Core
(Dr. S.A. Johnston’s Laboratory at Arizona State Univer-
sity) as previously explained [16].
Sample preparation and slide hybridization
The labeling and hybridization procedures was taken
from the protocol developed by The Institute for Geno-
mic Research [18] and adapted for our experiments [16].
Briefly, 10 μgo ft o t a lR N Af r o mB. melitensis 16 M
were reverse transcribed overnight to amino-allyl cDNA
using 1.5 μgo fBmGDPs or 6 μg of random hexamer
primers (Invitrogen). The reaction was stopped by incu-
bating the samples with 1 M NaOH and neutralized
with 1 M HCl. Samples were incubated with Cy3 dye
ester (Amersham Pharmacia Biosciences, Piscataway,
NJ) in 0.1 M sodium carbonate buffer (pH 9,0) in the
dark for one hour. For labeling of B. melitensis gDNA,
1.5 μg of isolated DNA was directly labeled overnight
using Bioprime DNA labeling system (Gibco) according
to the manufacturer’s instructions, with the following
modifications: 63 μMo fBmGDPs was used instead of
random hexamer primers, and 5 μlo f1 0 ×d N T P sm i x
[1.2 mM each dATP, dGTP, dTTP; 0.6 mMdCTP; 10
mM Tris pH8.0; 1 mM EDTA] (Invitrogen) was used
instead of the mix from the kit along with 3 μlo f
Cy5dCTP (1 mM stock; Amersham). In both cases,
uncoupled dye was removed using PCR purification kit
(Qiagen) and dye incorporation calculated by Nano-
Drop® ND-1000 (NanoDrop).
Dried, labeled cDNA samples were resuspended in
nuclease-free water (Ambion) and mixed with 0.5 μgo f
labeled B. melitensis gDNA to the final volume of 35 μl.
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45°C until hybridization. Thirty five μl of 2× formamide-
based hybridization buffer [50% formamide; 10× SSC;
0.2% SDS] was added to each pre-annealed samples,
well mixed and applied to a pre-treated custom 3.2 K B.
melitensis oligo-array. Slides were hybridized at 45°C for
~20 h in a dark, humid chamber (Corning) and washed
for 10 min at 45°C with low stringency buffer [1× SSC,
0.2% SDS] followed by two 5-min washes in a higher
stringency buffer [0.1× SSC, 0.2% SDS and 0.1× SSC] at
room temperature with agitation. Slides were dried by
centrifugation at 800 × g for 2 min and immediately
scanned.
Data acquisition and microarray data analysis
Microarrays were scanned using a commercial laser
scanner (GenePix 4100; Axon Instruments Inc., Foster
City, CA) with independent excitation of the fluoro-
phores Cy3 and Cy5. Fluorescent signal and local back-
ground intensities were quantified for each spot by
using image analysis software (GenePixPro 6.0; Axon
Instruments Inc.). Genes with fluorescent signal values
below background were disregarded in all analyses and
the arrays were normalized against B. melitensis geno-
mic DNA, as previously described [19]. Data were ana-
lyzed using GeneSifter (VizX Labs, Seattle, WA).
Regression analysis, Pearson’s correlation coefficient and
Spearman’s rank correlation were used to assess inter-
array and intra-array variability. After background sub-
traction and normalization, the signal values of every
gene (triplicate spots in 2 arrays = 6 spots) for each
experiment were averaged and pair-wise comparisons
performed for each group of samples. Individual pair-
wise comparison was performed to ensure reproducibil-
ity across replicates and for elimination of transcript
differences caused by normal sample variation. Student’s
t test was also performed, and genes were deemed as
significant if the p value was ≤ 0.05.
Results
Genome-directed primers (GDPs) generate more specific
probes of B. melitensis transcripts than random hexamer
primers (RHPs)
Talaat et al. (2004) and Lawson et al. (2006) demon-
strated the potential usefulness of GDPs for the detec-
tion of Mycobacterium tuberculosis and Yersinia pestis
gene expression in vivo, respectively [11,20]. In a techni-
cal experiment designed to determine the usefulness of
the GDPs for generation of cDNA from B. melitensis
mRNA and subsequent hybridization to microarrays, a
primer set (BmGDPs) generated from GDP-Finder soft-
ware was compared with a commercially available set of
RHPs. Each method was used on two identical B. meli-
tensis RNA samples isolated from log phase cultures,
and the resulting cDNA was labeled with Cy3 and
co-hybridized with Cy5-labeled genomic DNA (gDNA)
on two arrays for each primer type. Initially, the amount
of cDNA generated was lower using BmGDPs than
RHPs (5.7 μg vs. 7.5 μgf r o me v e r y1 0μg of total RNA),
which could be due to the selective annealing of
BmGDPs to B. melitensis mRNA. For inter-array com-
parison after labeling and hybridization, 63 of 9,681
spots with signal values flagged “bad” by GenePixPro 6.0
were removed across all four data sets to make them
comparable. The consistency of the signal from samples
reverse-transcribed with GDPs was slightly higher (R
2 =
0.7535) compared to RHPs samples (R
2 = 0.7116) (Figs.
1A and 1B). Linear regression analysis also revealed a
slightly higher advantage for GDPs (P value of 1.12 ×
10
-72, T statistic of 18.2) over RHPs (P value of 1.0 ×
10
-14, T statistic of 7.7). Likewise, correlation analysis
indicated that GDPs (87%) were slightly more consistent
than RHPs (84%), and the consistency was greater when
considering average signal intensity values (GDPs =
1665 & 1724 vs. 1912 & 1492 of RHPs), average stan-
dard deviation (490 vs. 540) and standard deviation of
average intensities (41 vs. 297). We also compared the
average ratio between experimental replicates (1.3 for
GDPs and 0.91 for RHPs), as well as the average signal
log ratio between each experimental replicate and the
co-hybridized gDNA (0.77 and 0.69 for GDPs and 0.69
and 0.83 for RHPs). While the average ratio between
experimental samples was higher for GDPs than for
RHPs, the standard deviation of signal log ratios, which
i sam o r er e l i a b l em e a s u r eo fc o n s i s t e n c yb e t w e e n
arrays, was lower (0.06 for GDPs and 0.10 for RHPs).
These results indicate greater consistency between
arrays hybridized with samples reverse-transcribed using
GDPs rather than RHPs.
We next examined the consistency between replicate
spots on each array (intra-array comparison). To
streamline the comparison, genes that were flagged as
“bad” and any “matching” replicate spots were removed
across all arrays. Eighty-one spots were eliminated,
which left 9,600 spots representing 3,200 different genes
(genes spotted in triplicate). The comparison of the
average signal values (GDPs = 1,668 & 1,726, RHPs =
1,915 & 1,494), their standard deviations (42 v 298) and
the average standard deviation between replicate spots
(GDPs = 257 & 190, RHPs = 296 & 290) essentially con-
firmed a higher intra-array consistency for the GDPs
over the RHPs samples. As a final measure of consis-
tency/variability between arrays, we separated all of the
replicate spots and treated them as replicate samples/
arrays in order to gauge the trend of consistency across
all replicate spots: two replicates (arrays) with triplicate
spots for each, yields 6 “theoretical arrays” for each con-
dition (GDPs and RHPs). The average R
2 value was
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despite similar standard deviations (0.10 for GDPs and
0.09 for RHPs). These results indicated that GDP repli-
cate spots were more similar to one another than were
RHP replicate spots. Altogether, these results indicate
that the reverse transcription of B. melitensis RNA using
GDPs generates more specific probes than those gener-
ated with RHPs.
BmGDPs and probes printed on the pathogen array select
against the hybridization of eukaryotic transcript
As BmGDPs are 8-mer oligonucleotide long primers, a
potential concern that they anneal and amplify contami-
nating RNA sequences from the host that overlap with
sequences of the B. melitensis transcripts and cross-
hybridized with probes on B. melitensis oligoarrays, was
considered. Total RNA isolated from HeLa cells culture
was labeled and hybridized on B. melitensis microarrays
under the same conditions as RNA isolated from
Brucella cultures. Initially, we observed a reduced
amount of cDNA generated (3.8 μgv s .9μgf r o m1 0μg
of HeLa RNA, and 3.1 μgv s .8 . 8μgf r o m1 0μgo f
MDBK RNA using BmGDPs or RHPs, respectively; vs.
5.7 μgf r o m1 0μgo fB. melitensis RNA), which indi-
cated some restriction of priming of BmGDPs to eukar-
y o t i cR N A .W h e nt h ec D N Ag e n e r a t e df r o mh o s tR N A
using BmGDPs was hybridized on the pathogen array,
only 105 of 3120 genes (3.3%) were consistently detected
(raw hybridization signal intensity values above 500 for
all 6 replicates -triplicate arrays on duplicate slides-), vs.
34% when RNA from B. melitensis was used. These data
illustrate that BmGDPs biased priming to B. melitensis
transcripts, along with the oligonucleotides printed on
pathogen array, highly reduce the chances of eukaryotic
transcripts to hybridize on the array.
The enrichment procedure enhanced B. melitensis RNA
concentration from the mixed Brucella:host RNA sample
To minimize the chances of falsely detected pathogen
genes due to the presence of eukaryotic RNA, we
enriched Brucella RNA from a host:pathogen mixed
RNA sample before amplification. Twenty-five μgo f
total eukaryote RNA from HeLa or MDBK cell lines was
mixed with 2 μgo fB. melitensis RNA (ratio 12.5:1). The
MICROB Enrich® kit (Ambion) was then used to remove
the eukaryotic RNA from the mixed sample. The total
RNA yield after treatment was 3.72 μg (an 86.2% reduc-
tion) and 4 μg (85% reduction) for HeLa:Brucella and
MDBK:Brucella mix, respectively. The integrity and
composition of the samples pre- and post-treatment
were evaluated by agarose gel electrophoresis and bioa-
nalyzed (Fig. 2A and 2B). These data effectively demon-
strate the usefulness of the enrichment procedure to
enrich the pathogen RNA and reduce the chances that
undesirable RNAs (i.e. host RNA) were inadvertently
subsequently amplified and eventually hybridized on the
pathogen array.
The biological information of B. melitensis transcriptome
is conserved after enrichment and amplification of mixed
RNA sample
To increase the template concentration when small
amounts of pathogen mRNA are present in the sample,
such as the early stage of infection, we linearly amplified
the enriched Brucella RNA. An important consideration
to take in account when extra procedures are applied on
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Figure 1 Inter-array comparison of signal consistency from B. melitensis RNA samples reverse transcribed with Genome Directed
Primers (GDPs) vs. Random Hexamer Primers (RHPs). The consistency of the signal generated from a Cy3-labeled B. melitensis cDNA using a
primer sets predicted from GDP-Finder software (GDPs) was compared with a Cy3-labeled B. melitensis cDNA made by a commercially available
set of RHPs. Each method was used on two sets of identical B. melitensis RNA samples isolated from late-log phase cultures, and the resulting
cDNA was labeled with Cy3 and co-hybridized with Cy5-labeled genomic DNA (gDNA) to two B. melitensis oligoarrays for each primer type.
Signal consistency from samples reverse transcribed with GDPs was slightly higher (R
2 = 0.7535) (A) compared to RHPs samples (0.7116) (B).
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nal information is maintained. A degree of potential bias
that may be introduced using the enrichment and
amplification (E&A) procedures and the measure of the
reproducibility of the protocol were evaluated by spiking
2 different samples of 25 μg of total RNA extracted
from HeLa or MDBK cell culture with 0.2 μgo fB.
melitensis RNA (host:pathogen RNA = 125:1). The
mixed RNA samples were initially enriched, which
decreased the RNA concentration more than 88% (from
25 μgt ol e s st h a n3μg of total RNA). Then, 1:10
volume of the remaining RNA (i.e. 0.25 and 0.3 μgo f
total RNA) was amplified using a 3 step protocol
described in the M&M. This protocol enables amplifica-
tion of sense-stranded prokaryotic transcripts. One
round of amplification yielded more than 80 μgo f
amplified sense total RNA from each sample (>than
260-fold amplification). Two aliquots of 10 μgf r o m
every E&A RNA sample were indirectly labeled and co-
hybridized against B. melitensis gDNA on B. melitensis
microarrays (4 arrays). The degree of bias introduced by
the enrichment and amplification was determined by
evaluating the performance of the E&A RNA samples
against identical labeling and hybridization protocol
from non-treated B. melitensis RNA (i.e. RNA extracted
from a log culture).
Prior to analysis, spots that were flagged as “unaccep-
table” were removed leaving a total of 3,120 acceptable
spots (out of the original 3,227). We employed genomic
normalization to improve data quality and to compare
multiple samples in a minimum of experiments [19].
To compare the consistency of gene expression for each
sample type, the signal values for each slide were
graphed pairwise and fitted with trend lines. The result-
ing R
2 values (slopes) represented the level of consis-
tency (similarity) between each slide, which was similar
for biological and technical replicates (Table 1). The
overall level of consistency for controls was less than for
experimental replicates between slides. Also inter-slide
variability was higher than intra-slide variability. E&A
treatment decreased this variability, which suggests that
some level of signal for the B. melitensis control slides
might have been due to noise interference. We next
examined the average signal values for B. melitensis con-
trol RNA and for E&A mixed RNA. The results revealed
higher signals in control samples (987.5 vs. 800.5), but
the difference was small and indicates that amplification
does not necessarily correspond to a higher signal.
In order to evaluate the bias introduced by the enrich-
ment and amplification process and the reproducibility
28S
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23S
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18S
16S 23S
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16S
18S
23S
28S
Figure 2 Integrity and composition of the host:Brucella RNA samples pre- and post-treatment. Twenty-five (25) μg total eukaryote RNA
from human (HeLa S3) and bovine (MDBK) cell lines were mixed with 2 μgo fBrucella melitensis 16 M RNA (ratio 12.5:1) and treated with
MICROB Enrich™(Ambion) according to the instruction manual. (A) Agarose gel electrophoresis image. Lines 1 & 2: HeLa cell line:B.melitensis 16 M
RNA mix; lines 3 & 4: MDBK cell line:B.melitensis 16 M RNA mix; pre and post-treatment respectively. (B) Comparison of RNA composition from a
sample of MDBK cell line:B. melitensis 16 M pre and post-treatment with MICROB Enrich™ (Ambion) and examined on an Agilent 2100
Bioanalyzer. Ribosomal RNA subunits are indicated.
Table 1 Results of pairwise graphical comparisons
Samples R
2 value
Control (Cy5) Experimental
Slides (inter)
B. melitensis control 0.49 0.58
HeLa:Bmel E&A 0.52 0.79
Arrays (intra)
B. melitensis control 0.88 0.86
HeLa:Bmel E&A 0.86 0.97
E&A: enriched and amplified
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(Spearman’s rank correlation coefficient, r) between the
fluorescence intensity in E&A vs. control samples and
then compared the expression profiles of hybridizations
of 2 independently amplified RNA samples. Our results
confirmed a good correlation (r = 0.8496) between the
expression profile of the E&A samples against the con-
trol sample and a high degree of correlation between
independent replicates (r = 0.9823). Altogether, these
results suggest that our protocol is highly reproducible
with a high level of maintenance of the original informa-
tion. Considering the fact that the magnitude of the bias
can be under-estimated when it is highly reproducible
[21], our results from preliminary experiments indicate
that enrichment of the original RNA sample followed by
the biased amplification of pathogen transcripts is suffi-
cient to accurately characterize the transcriptome of
intracellular pathogens in in vitro or in vivo systems of
infection.
Discussion
Modern technology has made gene expression detection
of mammalian systems straightforward and robust.
However, the study of the transcriptional profile of
intracellular bacteria is challenging due to the difficulty
of obtaining adequate high quality pathogen RNA free
of eukaryotic-RNA for downstream applications.
To reduce the interference of host RNA from the het-
erogeneous population of RNA, we used a commercial
kit to significantly reduce the eukaryotic RNA and
enrich the Brucella RNA. However, the enrichment pro-
cedure by itself does not address the challenge of a
small amount of Brucella RNA present in the initial
material (i.e., at the onset of the infection) that is insuf-
ficient for microarray studies. To increase the Brucella
RNA concentration and simultaneously minimize the
contaminated host RNA in the mixed sample, we
applied a protocol of linear amplification of sense-
stranded RNA biased to pathogen transcripts in the pre-
viously enriched RNA sample. In the first step, the pro-
tocol utilizes BmGDPs to bias the reverse transcription
to bacterial transcripts and the overhang tailing activity
o fM o l o n e ym u r i n el e u k e m i av i r u s( M M L V )r e v e r s e
transcriptase to add the T7 promoter to cDNAs during
reverse transcription. Then, the second-strand cDNA is
synthesized, and finally in vitro transcription is carried
out using a T7 polymerase. The methodology was repro-
ducible, as indicated by correlation analysis of the gene
expression detected in an original sample (non-enriched
non-amplified B. melitensis RNA) vs. an E&A host:
pathogen mixed RNA sample (i.e. B. melitensis RNA
spiked with HeLa RNA = 1:125). Bearing in mind that
the presence of contaminant eukaryotic RNA and the
extra handling of the samples could introduce some
degree of bias into the population of treated RNA [22],
the analysis of our results yielded a high correlation (r =
0.8496) between these 2 samples with high reproducibil-
ity of the technique (correlation between independent
replicates = 0.9823). This result is in concordance with
previous correlation study of pathogen gene expression
from a mixed host:pathogen RNA sample with the origi-
nal pathogen RNA sample [23]. Other studies focused
on validation of the methodology for RNA amplification
in the sense orientation showed a correlation between
“pure” samples before and after amplification. Making
the same comparison (i.e. unamplified vs. amplified B.
melitensis RNA), our study yielded a higher correlation
level compared to other studies [r = 0.81398 vs. 0.77
[15] or 0.8009 [22]) (data not shown). Amplification of
mixed RNA samples without previous enrichment did
yield the lowest correlation compared to the original B.
melitensis RNA sample (r = 0.38296). These results dif-
fer from another study that found a more complete bac-
teria global expression profile applying direct
amplification on the host:pathogen mixed sample [20].
A possible explanation may be that the ratio of bacter-
ial:host RNA in our study was much lower, as a conse-
quence of the presence of a higher level of contaminant
eukaryotic RNA.
Another potential concern was that eukaryotic RNA
present in the sample may interfere with pathogen gene
expression detection. This possibility is remote due to
the different levels of filters applied (i.e., the initial
enrichment treatment of the sample, the bias primed of
BmGDPs to B. melitensis transcripts, the specific
sequences of probes on the pathogen array), which
select against the host RNA amplification, labeling and
hybridization. However, if one desires to eliminate any
doubt, one could hybridize in parallel, the untreated
infected sample on the pathogen array and disregard
from future analysis all those spots that produced a sig-
nal in the untreated sample. This novel alternative,
which has not been reported in previous studies that
have evaluated the in vivo or in vitro transcriptional
profile of intracellular bacteria using similar strategies
[11,12,24], decreases the sensitivity but increases the
specificity of the system (i.e. some true positive
expressed pathogen genes might be disregarded from
the analysis but detected genes will be unambiguously
pathogen-associated genes).
In conclusion, we describe a 2-step protocol that pro-
vides for an enrichment of the original RNA sample
followed by the biased linear amplification of pathogen
transcripts that is potentially sufficient to accurately
Rossetti et al. BMC Research Notes 2010, 3:244
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Page 7 of 8characterize the transcriptome of intracellular pathogens
in in vitro or in vivo systems of infection.
Additional material
Additional file 1: B. melitensis 16 M genome-directed primers
(BmGDPs). This table describes the minimal number (89) of primers to
specifically anneal to the 3,198 B. melitensis ORFs. Primers were designed
using a computer-based algorithm (GDP-Finder) that predicts reverse
primers of 8-mer oligonucleotides required to anneal to all ORFs in a
given genome.
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